AR008309A1 - Formulaciones de aerosol en suspensión de furoato de mometasona , usos de de las mismas e inhalador de dosis de medida - Google Patents

Formulaciones de aerosol en suspensión de furoato de mometasona , usos de de las mismas e inhalador de dosis de medida

Info

Publication number
AR008309A1
AR008309A1 ARP970103860A ARP970103860A AR008309A1 AR 008309 A1 AR008309 A1 AR 008309A1 AR P970103860 A ARP970103860 A AR P970103860A AR P970103860 A ARP970103860 A AR P970103860A AR 008309 A1 AR008309 A1 AR 008309A1
Authority
AR
Argentina
Prior art keywords
formulations
mometasone furoate
suspension aerosol
dose inhaler
measuring dose
Prior art date
Application number
ARP970103860A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR008309A1 publication Critical patent/AR008309A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Formulaciones de aerosol en suspensión que exhiben tamanos de partículas estables, que contienen furoato de mometasona, de aproximadamente 1 aaproximadamente 10 por ciento por peso de etanol y 1,1,1,2,3,3,3- heptafluoropropano comoi mpelente. Se puede incluir asimismo un surfactante,tal como ácido oleico. Estas formulaciones son adecuadas para utilizar en nebulizadores de dosis medida. Asimismo incluye un nebulizador de dosis medidaque contiene dicha formulación.
ARP970103860A 1996-08-29 1997-08-26 Formulaciones de aerosol en suspensión de furoato de mometasona , usos de de las mismas e inhalador de dosis de medida AR008309A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70536896A 1996-08-29 1996-08-29

Publications (1)

Publication Number Publication Date
AR008309A1 true AR008309A1 (es) 1999-12-29

Family

ID=24833161

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103860A AR008309A1 (es) 1996-08-29 1997-08-26 Formulaciones de aerosol en suspensión de furoato de mometasona , usos de de las mismas e inhalador de dosis de medida

Country Status (31)

Country Link
EP (1) EP0927037B1 (es)
JP (1) JP3264496B2 (es)
KR (1) KR100316358B1 (es)
CN (1) CN1162157C (es)
AR (1) AR008309A1 (es)
AT (1) ATE202936T1 (es)
AU (1) AU719079B2 (es)
BR (1) BR9711445A (es)
CA (1) CA2263905C (es)
CO (1) CO4900027A1 (es)
CZ (1) CZ294064B6 (es)
DE (1) DE69705628T2 (es)
DK (1) DK0927037T3 (es)
ES (1) ES2159148T3 (es)
GR (1) GR3036674T3 (es)
HK (1) HK1018206A1 (es)
HU (1) HU227915B1 (es)
ID (1) ID18137A (es)
IL (1) IL128714A (es)
MY (1) MY117377A (es)
NO (1) NO322528B1 (es)
NZ (1) NZ334112A (es)
PE (1) PE100198A1 (es)
PL (1) PL189036B1 (es)
PT (1) PT927037E (es)
SA (1) SA97180339B1 (es)
SK (1) SK282147B6 (es)
TR (1) TR199900379T2 (es)
TW (1) TW475901B (es)
WO (1) WO1998008519A1 (es)
ZA (1) ZA977668B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
MXPA05002060A (es) * 2002-08-23 2005-06-08 Schering Corp Composiciones farmaceuticas.
WO2004020289A1 (en) * 2002-08-27 2004-03-11 Schering Corporation Process for producing metered dose inhaler formulations
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
JP2010518076A (ja) * 2007-02-09 2010-05-27 シェーリング コーポレイション 安定な医薬エアロゾル製剤
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
ATE203902T1 (de) * 1991-06-10 2001-08-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
WO1992022287A1 (en) * 1991-06-10 1992-12-23 Schering Corporation Non-chlorofluorocarbon aerosol formulations
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
PT927037E (pt) 2001-10-31
IL128714A (en) 2003-05-29
SK25399A3 (en) 1999-12-10
DK0927037T3 (da) 2001-09-24
AU719079B2 (en) 2000-05-04
WO1998008519A1 (en) 1998-03-05
NO990956D0 (no) 1999-02-26
HU227915B1 (en) 2012-05-29
ID18137A (id) 1998-03-05
DE69705628T2 (de) 2002-05-08
NO322528B1 (no) 2006-10-16
CN1162157C (zh) 2004-08-18
CA2263905C (en) 2002-05-14
PL189036B1 (pl) 2005-06-30
PE100198A1 (es) 1999-01-11
TW475901B (en) 2002-02-11
BR9711445A (pt) 1999-08-24
NO990956L (no) 1999-04-28
ES2159148T3 (es) 2001-09-16
EP0927037A1 (en) 1999-07-07
ATE202936T1 (de) 2001-07-15
CO4900027A1 (es) 2000-03-27
AU4232997A (en) 1998-03-19
KR100316358B1 (ko) 2001-12-12
PL331828A1 (en) 1999-08-02
CZ294064B6 (cs) 2004-09-15
NZ334112A (en) 2000-07-28
HK1018206A1 (en) 1999-12-17
ZA977668B (en) 1998-02-26
MY117377A (en) 2004-06-30
KR20000035879A (ko) 2000-06-26
IL128714A0 (en) 2000-01-31
DE69705628D1 (de) 2001-08-16
EP0927037B1 (en) 2001-07-11
SA97180339B1 (ar) 2006-01-31
CN1233960A (zh) 1999-11-03
CZ63299A3 (cs) 1999-07-14
CA2263905A1 (en) 1998-03-05
JP2000503673A (ja) 2000-03-28
HUP9902675A2 (hu) 2000-01-28
HUP9902675A3 (en) 2000-02-28
GR3036674T3 (en) 2001-12-31
TR199900379T2 (xx) 1999-05-21
SK282147B6 (sk) 2001-11-06
JP3264496B2 (ja) 2002-03-11

Similar Documents

Publication Publication Date Title
AR008309A1 (es) Formulaciones de aerosol en suspensión de furoato de mometasona , usos de de las mismas e inhalador de dosis de medida
NZ534040A (en) Metered dose inhaler
ME00220B (me) Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
ES2084360T3 (es) Formulaciones de aerosoles exentas de clorofluorocarbonos.
ME00333B (me) Farmaceutski aerosolni preparat
ES2176355T3 (es) Formulaciones de aerosol de peptidos y proteinas.
DE69928665D1 (de) Wässrige zusammenstellungen die corticosteroide enthalten zur nasalen oder pulmonalen verabreichung
MY121789A (en) Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage
BR9916865A (pt) Composição farmacêutica em aerossol contendohfa 227 e hfa 134a
BR9915095A (pt) Composição farmacêutica ministrável em aerosol
ATE308317T1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
AR018891A1 (es) Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol
PE20080204A1 (es) Formulaciones farmaceuticas que comprenden un anticolinergico y un beta agonista
GB0323684D0 (en) Improvements in or relating to organic compounds
BR9810729A (pt) Composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsionante
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
CA2355651A1 (en) Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
IT1317720B1 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
PE20011271A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
AR060072A1 (es) Aerosoles dosificadores para la administracion de preparaciones farmaceuticas
IT1260155B (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
ECSP972240A (es) Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos
TH59551B (th) สูตรผสมที่มียากลูโคคอร์ทิคอยด์สำหรับการรักษาของโรคเกี่ยวกับปอดและหลอดลม
GB935736A (en) Headache remedy

Legal Events

Date Code Title Description
FG Grant, registration